Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.530
0.00 (0.00%)
Jan 23, 2025, 12:08 PM EST - Market open
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $73.05 million as of January 23, 2025. Its market cap has decreased by -86.54% in one year.
Market Cap
73.05M
Enterprise Value
-15.14M
1-Year Change
-86.54%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $73.05M, a decrease of -77.42%. That is a compound annual growth rate of -34.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 73.05M | -4.53% |
| Dec 31, 2024 | 76.52M | -87.78% |
| Dec 29, 2023 | 626.15M | -13.15% |
| Dec 30, 2022 | 720.93M | 150.50% |
| Dec 31, 2021 | 287.80M | -11.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.91B |
| UnitedHealth Group | 478.29B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.76B |
| AbbVie | 299.00B |
| Merck & Co. | 242.04B |
| Thermo Fisher Scientific | 219.78B |
| Intuitive Surgical | 217.43B |